European AI Act

Home/European AI Act

Last updated: April 2026

This EU AI Act Transparency Notice ("Notice") describes how Biostarks uses artificial intelligence ("AI") systems in connection with its products and services, and sets out Biostarks' commitment to comply with Regulation (EU) 2024/1689 of the European Parliament and of the Council (the "EU AI Act") as its provisions progressively enter into force.

This Notice applies to individuals who access Biostarks' platforms, products, or services from within the European Union or who are otherwise subject to EU law. For general questions about how we handle your personal data, please review our Privacy Policy.

If there is a conflict between this Notice and any other Biostarks policy regarding AI-related processing, this Notice controls to the extent required by applicable law.


1. Who we are

AMR Labs SA ("Biostarks", "we", "us", "our") provides wellness-focused at-home biomarker testing and related digital services.

Controller / business contact details:
AMR Labs SA (Biostarks)
Rue des Bosquets 31, 1800 Vevey, Switzerland
Email: hello@biostarks.com


2. How Biostarks uses AI

Biostarks uses AI-assisted tools in limited, defined contexts to support the delivery of its wellness services. Current and anticipated uses include:

  • Result interpretation and reporting: AI models may assist in generating personalized wellness insights, contextualizing biomarker values, or structuring reports based on your test results. These outputs are informational only and do not constitute medical diagnoses.

  • Content personalization: AI may be used to tailor educational content, wellness recommendations, or messaging displayed within the Biostarks platform based on your profile and results.

  • Internal operations: AI tools may support internal functions such as quality control, customer support workflows, or data processing tasks that do not directly affect you as a user.

Biostarks does not use AI systems to make decisions that produce legal effects or similarly significant impacts on individuals. All outputs generated with AI assistance are intended as informational tools to support your personal wellness journey — not to replace professional medical judgment.


3. Risk classification under the EU AI Act

The EU AI Act establishes a risk-based framework categorizing AI systems as unacceptable risk, high risk, limited risk, or minimal risk.

Biostarks' current AI use cases are assessed as limited risk or minimal risk under this framework. AI systems used to generate wellness insights or personalized content fall within the limited risk category, which triggers transparency obligations — including this Notice.

Biostarks does not deploy AI systems classified as high risk under Annex III of the EU AI Act, including systems designed to make consequential automated decisions in healthcare, employment, or other regulated domains.

What this means for you

Because our AI systems fall within the limited risk category, we are required to ensure you are aware when you are interacting with or receiving outputs from an AI system. This Notice fulfils that obligation. Where relevant, additional in-product disclosures will be provided at the point of interaction.


4. Transparency and human oversight

Where AI is involved in generating content, insights, or recommendations that you may rely on, Biostarks is committed to:

  • Disclosing AI involvement: clearly indicating when content or outputs have been generated or materially assisted by an AI system.

  • Maintaining human oversight: ensuring that outputs affecting your wellness data or reports are subject to review or validation processes, and are not presented as autonomous determinations.

  • Providing context: ensuring that AI-generated outputs are accompanied by appropriate explanations of their scope, limitations, and informational nature.

  • Avoiding manipulation: Biostarks' AI systems do not employ subliminal techniques, exploit psychological vulnerabilities, or engage in deceptive practices of any kind.


5. Third-party AI tools

Biostarks may use third-party AI providers (such as cloud-based language or analytics models) as part of its service delivery. Where such providers process your personal data, they do so under contractual safeguards consistent with applicable data protection law, including the GDPR.

We may share data with the following categories of AI-related service providers, strictly to perform services on our behalf and subject to contractual safeguards:

  • AI inference and language model providers (e.g., generating structured wellness insights or report content from your test results)

  • Analytics and personalization platforms (e.g., adapting content or recommendations based on your usage patterns and results)

  • Quality assurance and monitoring tools (e.g., evaluating accuracy and consistency of AI-generated outputs)


We do not permit third-party AI providers to use your data for their own model training, commercial purposes, or any use beyond the specific service performed on our behalf.


6. Your rights in connection with AI

Where Biostarks uses AI in ways that may affect you, you have the right to:

  • Request information: confirm whether and how AI was used in generating content, insights, or outputs you received from Biostarks.

  • Request human review: obtain a human review of any AI-assisted output that you believe is inaccurate, incomplete, or inappropriately applied to your situation.

  • Withdraw consent: withdraw consent for any AI-assisted processing for which consent is the applicable legal basis, without affecting processing already completed.

  • Request correction: request correction of inaccurate data that may have influenced an AI-generated output (where applicable).

How to exercise your rights

Email hello@biostarks.com with the subject line: "EU AI Act — Request" and include:

  • Your full name

  • The email used for your Biostarks account (if any)

  • The right you want to exercise (information / human review / withdraw consent / correction)

  • Any helpful context (order ID, kit ID, approximate dates, description of the output concerned)

We will take reasonable steps to verify your identity before fulfilling the request.


7. Ongoing compliance commitment

The EU AI Act is being phased in progressively, with different provisions applying at different dates between 2024 and 2027. Biostarks is actively monitoring its obligations as they become applicable and is committed to updating its practices, documentation, and internal processes accordingly.

This includes, as relevant:

  • Technical documentation: maintaining records for applicable AI systems as required by the Act.

  • Conformity assessments: conducting appropriate assessments when required for the AI systems we deploy.

  • EU database registration: registering applicable systems in the EU AI Act database when required.

  • Notice updates: revising this Notice to reflect changes in our AI use or in the applicable regulatory framework.


8. Changes to this Notice

We may update this Notice from time to time as our use of AI evolves or as regulatory requirements are clarified. If we make material changes, we will post the updated Notice and revise the "Last updated" date above.


9. Contact us

Questions or requests: hello@biostarks.com

This Notice is effective as of April 2026 and replaces all previous versions.